HNGE | Ticker Profile - Titan Protect

HNGE

Hinge Health, Inc.

Healthcare · Health Information Services · NYQ

$63.62

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$4.1B

Total market value of the company

Trailing P/E

N/A

Forward P/E

17.16

Based on estimated future earnings — lower means cheaper

Rev Growth

+47.2%

Year-over-year revenue change

Profit Margin

-78.9%

How much profit the company keeps from each dollar of revenue

ROE

-136.0%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$70.00

+10% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 15 analysts covering this stock

About Hinge Health, Inc.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

https://www.hingehealth.com

Country: United States Employees: 1,437 Industry: Health Information Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.903

Good returns relative to risk taken

Kelly Fraction

0.0690

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

0.941

Acceptable balance between returns and drawdown risk

Annual Return

45.7%

Historical annualised return based on price data

Max Drawdown

-48.5%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

N/A

52W High

$62.18

-2% below the year high

52W Low

$30.08

112% above the year low

Avg Volume

1,177,203

Average daily shares traded — higher means easier to buy and sell

Short Ratio

2.8

Days it would take all short sellers to cover — higher means more crowded

Short % Float

7.8%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-8.92

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

2.24

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.30

Adequate but worth monitoring

Quick Ratio

1.04

Like current ratio but excludes inventory — stricter test

Gross Margin

81.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

17.6%

Profit from core operations before interest and tax

Free Cash Flow

$447M

Positive — the business generates more cash than it spends

Revenue (TTM)

$646M

Total revenue over the last 12 months

Net Income

$-511,388,992

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$95.00

Target Median

$70.00

Target Low

$55.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go